| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On June 13, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2002P-0444
|
| cefpodoxime Proxetil talbets for Oral suspension 50mg/100mg
|
|
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
|
|
|
| 2004Q-0097
|
| Qualified Health Claim: Calcium and various cancers
|
|
|
|
|
| 2004Q-0099
|
| Qualified Health Claim: Calcium and menstrual disorders
|
|
|
|
|
| 2004Q-0102
|
| Qualified Health Claim: Calcium and Kidney/urinary stones
|
|
|
|
|
| 2005D-0112
|
| Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
|
|
|
|
|
| 2005N-0217
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Product Voluntary Reporting Program
|
|
|
|
|
| 2005P-0139
|
| withdrawal of approvals of certain herdwide/flockwide uses of critically and highly important antibiotics pursuant to guidance #152
|
|
|
|
|
| 2005P-0228
|
| ANDA Suitability for Ranitidine Hydrochloride Suspension (15 mg base/mL)
|
|
|
|
|
| 2005V-0229
|
| Mobile Laser Show
|
|
|
|
|
| 2005V-0230
|
| Laser Light Show
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
16183
|
| Amrita Veda
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16184
|
| Garden of Life, Inc.
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16185
|
| Garden of Life, Inc.
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16186
|
| Garden of Life, Inc.
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16187
|
| Garden of Life, Inc.
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16188
|
| Eu Yan Sang (Hong Kong) Limited
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16189
|
| Garden of Life, Inc.
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16190
|
| Enzymatic Therapy
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16191
|
| Enzymatic Therapy
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16192
|
| Pharmavite LLC
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16193
|
| Enzymatic Therapy
|
| Vol #:
|
| 143
|
|
|
|
|
| LET
16194
|
| Michael Naturopathic Programs
|
| Vol #:
|
| 143
|
|
|
|
|
| 2002P-0444
|
| cefpodoxime Proxetil talbets for Oral suspension 50mg/100mg
|
|
|
|
|
| C
1
|
| The Weinberg Group, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
|
|
| MO 7
|
| HFZ-215
|
| Vol #:
|
| 2
|
|
|
|
|
| MO 8
|
| HFZ-215
|
| Vol #:
|
| 3
|
|
| |
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
|
|
| | | | | | | | |
|
|
|
|
| EXT
1
|
| Dressings & Sauces
|
| Vol #:
|
| 5
|
|
|
|
|
| EXT
2
|
| Food Products Association
|
| Vol #:
|
| 5
|
|
| |
|
| 2004Q-0097
|
| Qualified Health Claim: Calcium and various cancers
|
|
|
|
|
| LET
8
|
| Emord & Associates, P.C.
|
| Vol #:
|
| 15
|
|
|
|
|
| EXT 3
|
| NUMBER NOT USED
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004Q-0099
|
| Qualified Health Claim: Calcium and menstrual disorders
|
|
|
|
|
| LET
8
|
| Emond & Associated, P.C.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004Q-0102
|
| Qualified Health Claim: Calcium and Kidney/urinary stones
|
|
|
|
|
| LET
8
|
| Emord & Associated, P.C
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0112
|
| Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
|
|
|
|
|
| C
4
|
| Millennium Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0217
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Product Voluntary Reporting Program
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0139
|
| withdrawal of approvals of certain herdwide/flockwide uses of critically and highly important antibiotics pursuant to guidance #152
|
|
|
|
|
| C
1
|
| State of Utah
|
| Vol #:
|
| 1
|
|
| |
|
| 2005P-0228
|
| ANDA Suitability for Ranitidine Hydrochloride Suspension (15 mg base/mL)
|
|
|
|
|
| ACK
1
|
| HFA-305 to Lachman Consuting Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Lachman Consuting Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005V-0229
|
| Mobile Laser Show
|
|
|
|
|
| ACK
1
|
| HFA-305 to Anaphase Design
|
| Vol #:
|
| 1
|
|
|
|
|
| VAR
1
|
| Anaphase Design
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005V-0230
|
| Laser Light Show
|
|
|
|
|
| ACK
1
|
| HFA-305 to Crazy Horse Memorial
|
| Vol #:
|
| 1
|
|
|
|
|
| VAR
1
|
| Crazy
Horse Memorial
|
| Vol #:
|
| 1
|
|
